Keyword search (4,165 papers available)

"Harm" Keyword-tagged Publications:

Title Authors PubMed ID
1 Biotuner: A python toolbox integrating music theory and signal processing for harmonic analysis of physiological and natural time series Bellemare-Pepin A; Jerbi K; 41269470
PSYCHOLOGY
2 Post-subsidy Era: Potential for Carbon Pricing in Industrial Fisheries among Global Major Fishing Countries Peng H; Hao J; Lyu L; Wan S; An C; 40737555
ENCS
3 Efficacy of cognitive behavioral therapy for insomnia and lemborexant medication for different subtypes of chronic insomnia: study protocol for a randomized controlled trial Chen SJ; Ivers H; Dang-Vu TT; Shapiro CM; Carney CE; Robillard R; Morin CM; 40346496
HKAP
4 A scoping review of harm reduction practices and possibilities among indigenous populations in Australia, Canada, and the United States Zolopa C; Clifasefi SL; Dobischok S; Gala N; Fraser-Purdy H; Phillips MK; Blackmore S; Wendt DC; 39970577
PSYCHOLOGY
5 Face Boundary Formulation for Harmonic Models: Face Image Resembling Huang HT; Li ZC; Wei Y; Suen CY; 39852327
CONCORDIA
6 Editorial: Insight in non-pharmacological treatment of pain-2023 Geoffrey Dover 39697557
HKAP
7 In silico molecular targets, docking, dynamics simulation and physiologically based pharmacokinetics modeling of oritavancin Fatoki TH; Balogun TC; Ojewuyi AE; Omole AC; Olukayode OV; Adewumi AP; Umesi AJ; Ijeoma NP; Apooyin AE; Chinedu CP; Idowu IE; Isah MJ; 39439008
CHEMBIOCHEM
8 Emerging hazardous chemicals and biological pollutants in Canadian aquatic systems and remediation approaches: A comprehensive status report Adeola AO; Paramo L; Fuoco G; Naccache R; 39278485
CHEMBIOCHEM
9 Gambling Patterns and Problems of Gamblers on Licensed and Unlicensed Sites in France Costes JM; Kairouz S; Eroukmanoff V; Monson E; 25862019
SOCANTH
10 Insights into dietary phytochemicals targeting Parkinson's disease key genes and pathways: A network pharmacology approach Sasikumar DSN; Thiruselvam P; Sundararajan V; Ravindran R; Gunasekaran S; Madathil D; Kaliamurthi S; Peslherbe GH; Selvaraj G; Sudhakaran SL; 38460310
CHEMBIOCHEM
11 Dopamine dysregulation in Parkinson's disease flattens the pleasurable urge to move to musical rhythms Pando-Naude V; Matthews TE; Højlund A; Jakobsen S; Østergaard K; Johnsen E; Garza-Villarreal EA; Witek MAG; Penhune V; Vuust P; 37724707
PSYCHOLOGY
12 The Effects of Non-Pharmaceutical Interventions on COVID-19 Cases, Hospitalizations, and Mortality: A Systematic Literature Review and Meta-Analysis Peters JA; Farhadloo M; 37362389
JMSB
13 Chronic pain in children and adolescents diagnosed with cancer: the challenge of mitigating the pain and the potential of integrating exercise into pain management Caru M; Alberts NM; Freeman MC; Dandekar SC; Rao P; McKeone DJ; Brown VI; McGregor LM; Schmitz KH; 36952029
PSYCHOLOGY
14 Toward a digital citizen lab for capturing data about alternative ways of self-managing chronic pain: An attitudinal user study Khalili-Mahani N; Woods S; Holowka EM; Pahayahay A; Roy M; 36188996
PERFORM
15 Young people in Australia discuss strategies for preventing the normalisation of gambling and reducing gambling harm Pitt H; Thomas SL; Randle M; Cowlishaw S; Arnot G; Kairouz S; Daube M; 35549692
CONCORDIA
16 Do the Consequences Experienced by the People in the Life of a Problem Gambler Differ Based on the Nature of Their Relationship with the Gambler? Ferland F; Blanchette-Martin N; Côté M; Tremblay J; Kairouz S; Nadeau L; Savard AC; L' Espérance N; Dufour M; 34286413
CONCORDIA
17 Interrogation of Bacillus anthracis SrtA active site loop forming open/close lid conformations through extensive MD simulations for understanding binding selectivity of SrtA inhibitors Selvaraj C; Selvaraj G; Mohamed Ismail R; Vijayakumar R; Baazeem A; Wei DQ; Singh SK; 34220215
BIOLOGY
18 Osseointegration Pharmacology: A Systematic Mapping Using Artificial Intelligence Mahri M; Shen N; Berrizbeitia F; Rodan R; Daer A; Faigan M; Taqi D; Wu KY; Ahmadi M; Ducret M; Emami E; Tamimi F; 33181361
CONCORDIA
19 More than a quarter century of the most prescribed sleeping pill: Systematic review of zolpidem use by older adults. Machado FV, Louzada LL, Cross NE, Camargos EF, Dang-Vu TT, Nóbrega OT 32360985
PERFORM
20 Wavelength-Selective Nonlinear Imaging and Photo-Induced Cell Damage by Dielectric Harmonic Nanoparticles. Kilin V, Campargue G, Fureraj I, Sakong S, Sabri T, Riporto F, Vieren A, Mugnier Y, Mas C, Staedler D, Collins JM, Bonacina L, Vogel A, Capobianco JA, Wolf JP 32282184
CNSR
21 Implementing deprescribing guidelines into frontline practice: Barriers and facilitators. Conklin J, Farrell B, Suleman S 30241874
CONCORDIA
22 Deprescribing guidelines: An international symposium on development, implementation, research and health professional education. Farrell B, Conklin J, Dolovich L, Irving H, Maclure M, McCarthy L, Moriarty F, Pottie K, Raman-Wilms L, Reeve E, Thompson W 30241875
CONCORDIA
23 Deprescribing: Future directions for research. Thompson W, Reeve E, Moriarty F, Maclure M, Turner J, Steinman MA, Conklin J, Dolovich L, McCarthy L, Farrell B 30241876
CONCORDIA
24 "It did not apply to me": poker players' perspectives of prevention messages. Morvannou A, Monson E, Savard AC, Kairouz S, Roy É, Dufour M 31933237
PSYCHOLOGY
25 Biomarkers, designs, and interpretations of resting-state fMRI in translational pharmacological research: A review of state-of-the-Art, challenges, and opportunities for studying brain chemistry. Khalili-Mahani N, Rombouts SA, van Osch MJ, Duff EP, Carbonell F, Nickerson LD, Becerra L, Dahan A, Evans AC, Soucy JP, Wise R, Zijdenbos AP, van Gerven JM 28145075
PERFORM
26 A comparison of the impact of physical exercise, cognitive training and combined intervention on spontaneous walking speed in older adults. Pothier K, Gagnon C, Fraser SA, Lussier M, Desjardins-Crépeau L, Berryman N, Kergoat MJ, Vu TTM, Li KZH, Bosquet L, Bherer L 29235076
PERFORM

 

Title:More than a quarter century of the most prescribed sleeping pill: Systematic review of zolpidem use by older adults.
Authors:Machado FVLouzada LLCross NECamargos EFDang-Vu TTNóbrega OT
Link:https://www.ncbi.nlm.nih.gov/pubmed/32360985?dopt=Abstract
DOI:10.1016/j.exger.2020.110962
Publication:Experimental gerontology
Keywords:AgingInsomniaInterventionPharmacotherapySleep disordersTreatment
PMID:32360985 Category:Exp Gerontol Date Added:2020-05-04
Dept Affiliation: PERFORM
1 Graduation Program in Medical Sciences, University of Brasilia, Campus Universitário Darcy Ribeiro, Brasília, DF 70910-900, Brazil.
2 Graduation Program in Medical Sciences, University of Brasilia, Campus Universitário Darcy Ribeiro, Brasília, DF 70910-900, Brazil; Geriatric Medical Centre, Brasilia University Hospital, SGAN 605 Av. L2 Norte, Brasilia, DF 70840-901, Brazil.
3 Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal (CRIUGM), 4545 chemin Queen-Mary, Montreal, Qc H3W 1W5, Canada; Center for Studies in Behavioral Neurobiology and PERFORM Center, Department of Health, Kinesiology and Applied Physiology, Concordia University, 7141 Sherbrooke Street West, Montreal, Qc H4B 1R6, Canada.
4 Graduation Program in Medical Sciences, University of Brasilia, Campus Universitário Darcy Ribeiro, Brasília, DF 70910-900, Brazil; Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal (CRIUGM), 4545 chemin Queen-Mary, Montreal, Qc H3W 1W5, Canada. Electronic address: otavionobrega@unb.br.

Description:

More than a quarter century of the most prescribed sleeping pill: Systematic review of zolpidem use by older adults.

Exp Gerontol. 2020 Apr 30;:110962

Authors: Machado FV, Louzada LL, Cross NE, Camargos EF, Dang-Vu TT, Nóbrega OT

Abstract

Zolpidem is widely used to treat insomnia of older adults despite that few randomized controlled studies were conducted in this group. We systematically reviewed the relevant literature on efficacy/effectiveness and safety of zolpidem use by elderly individuals in relevant databases completed with a manual search of key journals. Studies were required to include individuals aged =60?years under intervention with zolpidem compared to placebo or other hypnosedatives. Outcomes were either objectively- or subjectively-assessed improvements in specific sleep parameters and safety for clinical use. The 31 reports selected for review were mostly of low-quality. The evidence suggests that zolpidem is useful typically by reducing sleep latency and episodes of wake after sleep onset, and increasing total sleep time and sleep efficiency. Regarding safety and tolerability, analyses suggest a low risk of daytime sleepiness and of deleterious effects on memory or psychomotor performance, provided that recommended dosage and precautions are followed. Few retrospective studies associate zolpidem use with risk of falls, fractures, dementia, cancer, and stroke. Zolpidem appears effective at lower doses and for short-term treatment among the elderly. Rigorous, new clinical trials are warranted to further document the specific effects of zolpidem in older individuals.

PMID: 32360985 [PubMed - as supplied by publisher]





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University